Please login to the form below

Not currently logged in

heart disease

This page shows the latest heart disease news and features for those working in and with pharma, biotech and healthcare.

Roche’s Tamiflu successor hits the mark in complicated flu

Roche’s Tamiflu successor hits the mark in complicated flu

with other illnesses such as asthma, chronic lung disease, diabetes, or heart disease. ... Flu remains a major cause of death worldwide, leading to severe disease in 3 to 5 million people every year and causing around 650, 000 deaths.

Latest news

More from news
Approximately 6 fully matching, plus 305 partially matching documents found.

Latest Intelligence

  • Waking the sleeping giant Waking the sleeping giant

    While it is true that less than 50% of Africans enjoy access to modern healthcare facilities at present, and that Africa suffers from one-quarter of the world’s disease burden, ... In addition, SMS and voice messaging are being used for patient

  • Tackling the challenge of non-adherence Tackling the challenge of non-adherence

    Improving patient adherence… is one way of improving this efficiency as there is decreased spending on hospitalisations, re-admissions, disease progression and complications.”. ... 80% in just five disease areas - asthma, type 2 diabetes, coronary

  • A healthy challenge A healthy challenge

    All told, 50 million people in the EU are afflicted by conditions such as diabetes, congestive heart failure, chronic obstructive pulmonary disease and asthma, and in 2013 more than 1.2m

  • Deal Watch May 2016 Deal Watch May 2016

    Teva's drug SD 809 for the treatment of Huntington's disease was part of the acquisition of Auspex at a cost of $3.5bn. ... disease late last year, Bayer announced another gene editing pact this month with ERS Genomics.

  • Reaching new heights Reaching new heights

    Transformative medicine use. The overwhelming inertia in medicine use - where 97% of medicines used have been available for more than ten years - masks the contribution from transformative disease treatments, orphan drugs ... Disease treatments in 2020

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....